Literature DB >> 15180309

Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells.

Hyun-Sook Kim1, Eun-Hee Lee, Sung-Ryong Ko, Kang-Ju Choi, Jong-Hee Park, Dong-Soon Im.   

Abstract

Ginseng has an anti-cancer effect in several cancer models. This study was to characterize active constituents of ginseng and their effects on proliferation of prostate cancer cell lines, LNCaP and PC3. Cell proliferation was measured by [3H]thymidine incorporation, the intracellular calcium concentration by a dual-wavelength spectrophotometer system, effects on mitogen-activated protein (MAP) kinases by Western blotting, and cell attachment and morphologic changes were observed under a microscope. Among 11 ginsenosides tested, ginsenosides Rg3 and Rh2 inhibited the proliferation of prostate cancer cells. EC50s of Rg3 and Rh2 on PC3 cells were 8.4 microM and 5.5 microM, respectively, and 14.1 microM and 4.4 microM on LNCaP cells, respectively. Both ginsenosides induced cell detachment and modulated three modules of MAP kinases activities differently in LNCaP and PC3 cells. These results suggest that ginsenosides Rg3 and Rh2-induced cell detachment and inhibition of the proliferation of prostate cancer cells may be associated with modulation of three modules of MAP kinases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180309     DOI: 10.1007/bf02980085

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  65 in total

Review 1.  Role of phytochemicals in colorectal cancer prevention.

Authors:  Yu-Hua Li; Yin-Bo Niu; Yang Sun; Feng Zhang; Chang-Xu Liu; Lei Fan; Qi-Bing Mei
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

2.  Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway.

Authors:  Jian-Wen Jiang; Xin-Mei Chen; Xin-Hua Chen; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

3.  Ginsenoside metabolite compound K enhances the efficacy of cisplatin in lung cancer cells.

Authors:  Yang Li; Tong Zhou; Chengyuan Ma; Weiwei Song; Jian Zhang; Zhenxiang Yu
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

4.  Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling.

Authors:  Jung-Soo Bae; Hyoung-Sook Park; Jong-Wan Park; Shan-Hua Li; Yang-Sook Chun
Journal:  J Nat Med       Date:  2011-11-20       Impact factor: 2.343

5.  Ginsenoside Rb1 Enhances Keratinocyte Migration by a Sphingosine-1-Phosphate-Dependent Mechanism.

Authors:  Kyong-Oh Shin; Sung Jay Choe; Yoshikazu Uchida; Inyong Kim; Yoonhwa Jeong; Kyungho Park
Journal:  J Med Food       Date:  2018-08-27       Impact factor: 2.786

6.  Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.

Authors:  Xi-Ping Tang; Guo-Du Tang; Chun-Yun Fang; Zhi-Hai Liang; Lu-Yi Zhang
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

7.  Dammarane-type triterpene ginsenoside-Rg18 inhibits human non-small cell lung cancer A549 cell proliferation via G1 phase arrest.

Authors:  Dong-Gyu Leem; Ji-Sun Shin; Kyung-Tack Kim; Sang Yoon Choi; Myung-Hee Lee; Kyung-Tae Lee
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

8.  Potential role of ginseng in the treatment of colorectal cancer.

Authors:  Chong-Zhi Wang; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2008       Impact factor: 4.667

9.  Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases.

Authors:  Sunga Choi; Tae Woong Kim; Shivendra V Singh
Journal:  Pharm Res       Date:  2009-07-23       Impact factor: 4.200

10.  Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells.

Authors:  Xiaoji Luo; Chong-Zhi Wang; Jin Chen; Wen-Xin Song; Jinyong Luo; Ni Tang; Bai-Cheng He; Quan Kang; Yitao Wang; Wei Du; Tong-Chuan He; Chun-Su Yuan
Journal:  Int J Oncol       Date:  2008-05       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.